G-CSF Treatment for Stroke Recovery
Author Information
Author(s): Armin Schneider, Rainer Wysocki, Claudia Pitzer, Carola Krüger, Rico Laage, Stefan Schwab, Alfred Bach, Wolf-Rüdiger Schäbitz
Primary Institution: Axaron Bioscience AG
Hypothesis
Can delayed G-CSF treatment improve outcomes in cerebral ischemia?
Conclusion
G-CSF treatment significantly reduces infarct size and improves recovery in stroke models even when administered up to 72 hours after ischemia.
Supporting Evidence
- G-CSF reduced total infarct volume by 33% compared to vehicle-treated rats.
- Significant improvement in sensorimotor function was observed in G-CSF treated rats.
- Treatment with G-CSF was effective even when started 72 hours after ischemia.
Takeaway
G-CSF is a medicine that helps the brain heal after a stroke, and it works even if you start giving it a few hours after the stroke happens.
Methodology
Rats underwent middle cerebral artery occlusion (MCAO) and were treated with G-CSF at various time points; infarct volumes were measured after 24 hours.
Potential Biases
Potential bias due to the authors' affiliations with a company that produces G-CSF.
Limitations
The study was conducted in animal models, which may not fully translate to human stroke patients.
Participant Demographics
Male Wistar rats weighing 280 to 320 g.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website